DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Torcetrapib is an investigational drug.
There have been 17 clinical trials for Torcetrapib. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hyperlipidemias, Hypercholesterolemia, and Hyperlipoproteinemia Type II. The leading clinical trial sponsors are Pfizer, University of Utah, and Abbott.
Recent Clinical Trials for Torcetrapib
|A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)||Phase 1/Phase 2|
|A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels||PharmaNet||Phase 2|
|A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels||Dr. Reddy's Laboratories Limited||Phase 2|